Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial

Fabian Proft,Valeria Rios-Rodriguez,Denis Poddubnyy,Joachim Sieper,Burkhard Muche,Joachim Listing

doi:10.1136/bmjopen-2016-014591

Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial

Fabian Proft, Valeria Rios-Rodriguez + Show 4 more

Open Access

https://doi.org/10.1136/bmjopen-2016-014591

Copy DOI

Journal: BMJ open	Publication Date: Jun 1, 2017
Citations: 17	License type: open-access

Affiliation: Charité - Universitätsmedizin Berlin, German Rheumatism Research Centre

#Progression Of Structural Damage #Ankylosing Spondylitis + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionThere is some evidence that non-steroidal anti-inflammatory drugs (NSAIDs), in particular celecoxib, might possess not only a symptomatic efficacy but also disease-modifying properties in ankylosing spondylitis (AS), retarding the progression...

Full Text